Fostemsavir Tris
Fostemsavir Tris (BMS-663068 Tris) is an oral prodrug of the active attachment inhibitor BMS-626529. It blocks HIV-1 infection by binding to viral gp120, preventing its attachment to host CD4+ T-cells. This mechanism has been validated in both in vitro antiviral assays and in vivo clinical research for antiretroviral therapy.
Product Specifications
CAS Number
864953-39-9
Product Name Alternative
Field of Research
Infectious Disease & Virology, Pharmacology & Drug Discovery, Protein Biochemistry
Purity
99.45% (May vary between batches)
Solubility
H2O:100 mg/mL (141.92 mM) ; DMSO:125 mg/mL (177.4 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:4 mg/mL (5.68 mM)
Smiles
O=C (N1CCN (C (C2=CC=CC=C2) =O) CC1) C (C3=CN (COP (O) (O) =O) C4=C3C (OC) =CN=C4N5N=C (C) N=C5) =O.OCC (CO) (N) CO
Molecular Formula
C29H37N8O11P
Molecular Weight
704.62
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Recombinant Delftia acidovorans Alkanesulfonate monooxygenase (ssuD)
Recombinant Delftia acidovorans Alkanesulfonate monooxygenase (ssuD)
Recombinant Delftia acidovorans Alkanesulfonate monooxygenase (ssuD)
Recombinant Delftia acidovorans Alkanesulfonate monooxygenase (ssuD)
Recombinant Delftia acidovorans Alkanesulfonate monooxygenase (ssuD)